List of Precigen patents

Patents where

Current Assignee

Name

Precigen

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11535669 Fusion constructs and methods of using thereof	Patent 11535669 was granted and assigned to Precigen on December, 2022 by the United States Patent and Trademark Office.		Precigen	United States Patent and Trademark Office	11535669	December 27, 2022
‌ US Patent 11319380 MUC16 specific chimeric antigen receptors and uses thereof	Patent 11319380 was granted and assigned to Precigen on May, 2022 by the United States Patent and Trademark Office.	Precigen	Precigen	United States Patent and Trademark Office	11319380	May 3, 2022
‌ US Patent 11421235 Methods and microorganisms for the fermentation of methane to multi-carbon compounds			Precigen	United States Patent and Trademark Office	11421235	August 23, 2022
‌ US Patent 11608362 Hepatitis B vaccines and uses of the same	Patent 11608362 was granted and assigned to Precigen on March, 2023 by the United States Patent and Trademark Office.	Precigen	Precigen	United States Patent and Trademark Office	11608362	March 21, 2023
‌ US Patent 11198877 Molecular switches	Patent 11198877 was granted and assigned to Precigen on December, 2021 by the United States Patent and Trademark Office.	‌ Intrexon Corporation	Precigen	United States Patent and Trademark Office	11198877	December 14, 2021
‌ US Patent 11116852 Frataxin expression constructs	Patent 11116852 was granted and assigned to Precigen on September, 2021 by the United States Patent and Trademark Office.	Precigen	Precigen	United States Patent and Trademark Office	11116852	September 14, 2021
‌ US Patent 11118168 Expression of novel cell tags	Patent 11118168 was granted and assigned to Precigen on September, 2021 by the United States Patent and Trademark Office.	Precigen	Precigen	United States Patent and Trademark Office	11118168	September 14, 2021
‌ US Patent 10876137 Biological production of multi-carbon compounds from methane		‌ Intrexon Corporation	Precigen	United States Patent and Trademark Office	10876137	December 29, 2020
‌ US Patent 11034940 Expression of novel cell tags	Patent 11034940 was granted and assigned to Precigen on June, 2021 by the United States Patent and Trademark Office.	‌ Intrexon Corporation	Precigen	United States Patent and Trademark Office	11034940	June 15, 2021
‌ US Patent 11155837 Methods and microorganisms for making 1,4-butanediol and derivatives thereof from C1 carbons	Patent 11155837 was granted and assigned to Precigen on October, 2021 by the United States Patent and Trademark Office.	‌ Intrexon Corporation	Precigen	United States Patent and Trademark Office	11155837	October 26, 2021
‌ US Patent 11111496 Methods and microorganisms for making 2,3-butanediol and derivatives thereof from C1 carbons	Patent 11111496 was granted and assigned to Precigen on September, 2021 by the United States Patent and Trademark Office.	‌ Intrexon Corporation	Precigen	United States Patent and Trademark Office	11111496	September 7, 2021
‌ US Patent 11154622 Compositions and methods for expression of multiple biologically active polypeptides from a single vector for treatment of cardiac conditions and other pathologies	Patent 11154622 was granted and assigned to Precigen on October, 2021 by the United States Patent and Trademark Office.	Precigen	Precigen	United States Patent and Trademark Office	11154622	October 26, 2021
‌ US Patent 11771718 Polypeptide compositions comprising spacers	Patent 11771718 was granted and assigned to Precigen on October, 2023 by the United States Patent and Trademark Office.	‌ Intrexon Corporation	Precigen	United States Patent and Trademark Office	11771718	October 3, 2023
‌ US Patent 11939584 Methods and microorganisms for making 2,3-butanediol and derivatives thereof from C1 carbons	Patent 11939584 was granted and assigned to Precigen on March, 2024 by the United States Patent and Trademark Office.	Precigen	Precigen	United States Patent and Trademark Office	11939584	March 26, 2024
‌ US Patent 11946054 Modulating expression of polypeptides via new gene switch expression systems	Patent 11946054 was granted and assigned to Precigen on April, 2024 by the United States Patent and Trademark Office.	Precigen	Precigen	United States Patent and Trademark Office	11946054	April 2, 2024
‌ US Patent 11976134 MUC16 specific chimeric antigen receptors and uses thereof	Patent 11976134 was granted and assigned to Precigen on May, 2024 by the United States Patent and Trademark Office.	Precigen	Precigen	United States Patent and Trademark Office	11976134	May 7, 2024
‌ US Patent 12018310 Methods and microorganisms for making 1,4-butanediol and derivatives thereof from C1 carbons	Patent 12018310 was granted and assigned to Precigen on June, 2024 by the United States Patent and Trademark Office.	Precigen	Precigen	United States Patent and Trademark Office	12018310	June 25, 2024
‌ US Patent 11998618 Frataxin expression constructs	Patent 11998618 was granted and assigned to Precigen on June, 2024 by the United States Patent and Trademark Office.	Precigen	Precigen	United States Patent and Trademark Office	11998618	June 4, 2024
‌ US Patent 11787848 CD33 specific chimeric antigen receptors	Patent 11787848 was granted and assigned to Precigen on October, 2023 by the United States Patent and Trademark Office.	Precigen	Precigen	United States Patent and Trademark Office	11787848	October 17, 2023
‌ US Patent 11981746 MUC16 specific chimeric antigen receptors and uses thereof	Patent 11981746 was granted and assigned to Precigen on May, 2024 by the United States Patent and Trademark Office.	Precigen	Precigen	United States Patent and Trademark Office	11981746	May 14, 2024
‌ US Patent 12091667 Molecular switches	Patent 12091667 was granted and assigned to Precigen on September, 2024 by the United States Patent and Trademark Office.	Precigen	Precigen	United States Patent and Trademark Office	12091667	September 17, 2024
‌ US Patent 11692194 Modulating expression of polypeptides via new gene switch expression systems		Precigen	Precigen	United States Patent and Trademark Office	11692194	July 4, 2023
‌ US Patent 12060585 Expression of novel cell tags	Patent 12060585 was granted and assigned to Precigen on August, 2024 by the United States Patent and Trademark Office.	Precigen	Precigen	United States Patent and Trademark Office	12060585	August 13, 2024

23 results

0 selected

23 results

0 selected